Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Aspen Aerogels (ASPN) EBITDA (2016 - 2025)

Aspen Aerogels' EBITDA history spans 13 years, with the latest figure at -$70.4 million for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA fell 578.38% year-over-year to -$70.4 million, compared with a TTM value of -$378.2 million through Dec 2025, down 793.55%, and an annual FY2025 reading of -$378.2 million, down 793.55% over the prior year.
  • EBITDA for Q4 2025 was -$70.4 million at Aspen Aerogels, down from -$3.3 million in the prior quarter.
  • The five-year high for EBITDA was $20.0 million in Q2 2024, with the low at -$299.3 million in Q1 2025.
  • Average EBITDA over 5 years is -$24.6 million, with a median of -$10.6 million recorded in 2021.
  • Year-over-year, EBITDA skyrocketed 963.85% in 2024 and then tumbled 12388.22% in 2025.
  • Tracing ASPN's EBITDA over 5 years: stood at -$16.3 million in 2021, then surged by 40.74% to -$9.7 million in 2022, then soared by 114.31% to $1.4 million in 2023, then skyrocketed by 963.85% to $14.7 million in 2024, then plummeted by 578.38% to -$70.4 million in 2025.
  • Per Business Quant, the three most recent readings for ASPN's EBITDA are -$70.4 million (Q4 2025), -$3.3 million (Q3 2025), and -$5.2 million (Q2 2025).